An unhealthy lifestyle is the main reason for the shift in the therapeutic regimen for patients with T2DM (19), starting with glucose-lowering medicines, followed by low-dose insulin, and then increasing the insulin dosage. Here, INS is linked to type 2 diabetes mellitus.